Lite Strategy, Inc. (LON:0JW9)
London · Delayed Price · Currency is GBP · Price in USD 1.150
+0.048 (4.36%)
Feb 12, 2026, 2:31 PM GMT
Lite Strategy Market Cap
Lite Strategy has a market cap or net worth of 28.84 million as of February 12, 2026. Its market cap has increased by 87.53% in one year.
Market Cap
28.84M
Enterprise Value
21.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.15
Market Cap Chart
Since December 18, 2003, Lite Strategy's market cap has decreased from 240.31M to 28.84M, a decrease of -88.00%. That is a compound annual growth rate of -9.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 28.84M | -20.04% |
| Dec 31, 2025 | 36.06M | 175.45% |
| Dec 31, 2024 | 13.09M | -56.85% |
| Dec 29, 2023 | 30.34M | 12.61% |
| Dec 30, 2022 | 26.94M | -89.71% |
| Dec 31, 2021 | 261.95M | 20.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.94B |
| Provexis | 35.07M |
| Poolbeg Pharma | 32.43M |
| ImmuPharma | 31.72M |
| Arecor Therapeutics | 28.70M |